| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |